The Frequencies Distribution of CYP3A5 Rs776746 and ABCB1 Rs1045642 Polymorphisms in the West Algerian Population and Relationships with Pharmacogenetics

Overview

Journal Afr Health Sci

Date 2024 Jul 4

PMID 38962329

Authors

Amina Ammour

Meriem Aberkane

Abdallah Boudjema

Wefa Boughrara

Sounnia Mediene Benchekor

Affiliations

Soon will be listed here.

Abstract

Introduction: Pharmacogenetic markers, such as the ATP Binding Cassette (ABCB1) and cytochrome P450 (CYP) 3A5 enzymes, play a crucial role in personalized medicine by influencing drug efficacy and toxicity based on individuals' or populations' genetic variations.This study aims to investigate the genetic polymorphisms of CYP3A5 (rs776746) and ABCB1 (rs1045642) in the West Algerian population and compare the genotypes and allelic distributions with those of various ethnic groups.

Methods: The study involved 472 unrelated healthy subjects from the Western Algerian population. DNA genotyping was performed using TaqMan allelic discrimination assay. The variants in our population were compared to those in other ethnic groups available in the 1000 Genomes Project. Genotype and allele frequencies were calculated using the chi-square test and the Hardy-Weinberg equilibrium (HWE).

Results: The minor allele frequencies were found to be 0.21 for CYP3A5 6986A and 0.34 for ABCB1 3435T. These frequencies were similar to those observed in North African populations, while notable differences were observed in comparison to certain Caucasian and African populations.

Conclusion: The difference in the allelic and genotypic distribution of these polymorphisms emphasize the need for dose adjustments in drugs metabolized by CYP3A5 and transported by ABCB1 to optimize treatments outcomes.

References

Turijan-Espinoza E, Ruiz-Rodriguez V, Uresti-Rivera E, Martinez-Leija E, Zermeno-Nava J, Guel-Panola A . Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients. Cancer Chemother Pharmacol. 2021; 87(6):843-853. DOI: 10.1007/s00280-021-04244-y. View

Ahmed S, Zhou Z, Zhou J, Chen S . Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics. 2016; 14(5):298-313. PMC: 5093856. DOI: 10.1016/j.gpb.2016.03.008. View

Maddin N, Husin A, Gan S, Aziz B, Ankathil R . Impact of and Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia. Oncol Ther. 2017; 4(2):303-314. PMC: 5315081. DOI: 10.1007/s40487-016-0035-x. View

Sim S, Ingelman-Sundberg M . The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects. Hum Genomics. 2010; 4(4):278-81. PMC: 3525213. DOI: 10.1186/1479-7364-4-4-278. View

Kudzi W, Dodoo A, Mills J . Genetic polymorphisms in MDR1, CYP3A4 and CYP3A5 genes in a Ghanaian population: a plausible explanation for altered metabolism of ivermectin in humans?. BMC Med Genet. 2010; 11:111. PMC: 3161347. DOI: 10.1186/1471-2350-11-111. View

Tulsyan S, Chaturvedi P, Singh A, Agarwal G, Lal P, Agrawal S . Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach. Gene. 2014; 543(1):69-75. DOI: 10.1016/j.gene.2014.04.004. View

Nassar S, Amro O, Abu-Rmaileh H, Alshaer I, Korachi M, Ayesh S . ABCB1 C3435T and CYP2C19*2 polymorphisms in a Palestinian and Turkish population: A pharmacogenetic perspective to clopidogrel. Meta Gene. 2015; 2:314-9. PMC: 4287958. DOI: 10.1016/j.mgene.2014.01.009. View

Tavira B, Gomez J, Diaz-Corte C, Coronel D, Lopez-Larrea C, Suarez B . The donor ABCB1 (MDR-1) C3435T polymorphism is a determinant of the graft glomerular filtration rate among tacrolimus treated kidney transplanted patients. J Hum Genet. 2015; 60(5):273-6. DOI: 10.1038/jhg.2015.12. View

Baker S, Verweij J, Cusatis G, van Schaik R, Marsh S, Orwick S . Pharmacogenetic pathway analysis of docetaxel elimination. Clin Pharmacol Ther. 2008; 85(2):155-63. PMC: 4612590. DOI: 10.1038/clpt.2008.95. View

10.

Tazzite A, Kassogue Y, Diakite B, Jouhadi H, Dehbi H, Benider A . Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis. BMC Genet. 2016; 17(1):126. PMC: 5007843. DOI: 10.1186/s12863-016-0434-x. View

11.

Mendrinou E, Mashaly M, Al Okily A, Mohamed M, Refaie A, Elsawy E . Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients. Front Pharmacol. 2020; 11:1218. PMC: 7431691. DOI: 10.3389/fphar.2020.01218. View

12.

Lalan S, Abdel-Rahman S, Gaedigk A, Leeder J, Warady B, Dai H . Effect of CYP3A5 genotype, steroids, and azoles on tacrolimus in a pediatric renal transplant population. Pediatr Nephrol. 2014; 29(10):2039-49. DOI: 10.1007/s00467-014-2827-2. View

13.

Novillo A, Romero-Lorca A, Gaibar M, Bahri R, Harich N, Sanchez-Cuenca D . Genetic diversity of CYP3A4 and CYP3A5 polymorphisms in North African populations from Morocco and Tunisia. Int J Biol Markers. 2014; 30(1):e148-51. DOI: 10.5301/jbm.5000118. View

14.

Al-Eitan L, Rababah D, Alghamdi M, Khasawneh R . Role of Four ABC Transporter Genes in Pharmacogenetic Susceptibility to Breast Cancer in Jordanian Patients. J Oncol. 2019; 2019:6425708. PMC: 6662487. DOI: 10.1155/2019/6425708. View

15.

Emich-Widera E, Likus W, Kazek B, Niemiec P, Balcerzyk A, Sieron A . CYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescents. Biomed Res Int. 2013; 2013:526837. PMC: 3747339. DOI: 10.1155/2013/526837. View

16.

Wu H, Kang H, Liu Y, Tong W, Liu D, Yang X . Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes. J Cancer Res Clin Oncol. 2012; 138(9):1449-62. DOI: 10.1007/s00432-012-1209-z. View

17.

Al-Eitan L, Al-Maqableh H, Mohammad N, Hakooz N, Dajani R . Genetic Analysis of Pharmacogenomic VIP Variants of ABCB1, VDR and TPMT Genes in an Ethnically Isolated Population from the North Caucasus Living in Jordan. Curr Drug Metab. 2020; 21(4):307-317. DOI: 10.2174/1389200221666200505081139. View

18.

Yan M, Fan X, Si H, Wang X, Wang Z, Wang Z . Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis. Cancer Chemother Pharmacol. 2022; 89(2):173-181. DOI: 10.1007/s00280-021-04374-3. View

19.

Miller S, Dykes D, Polesky H . A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3):1215. PMC: 334765. DOI: 10.1093/nar/16.3.1215. View

20.

Zhong J, Guo Z, Fan L, Zhao X, Zhao B, Cao Z . ABCB1 polymorphism predicts the toxicity and clinical outcome of lung cancer patients with taxane-based chemotherapy. Thorac Cancer. 2019; 10(11):2088-2095. PMC: 6825927. DOI: 10.1111/1759-7714.13184. View